AICDA and Alzheimer disease: However, previous reports suggested that the AID-ΔE4a variant differentially affects CSR and SHM function in vitro, rendering SHM active, a finding that is currently restricted to AD-AID patients with C-terminal AICDA mutations [25, 27, 28].